Yes, these technologies can guide personalized treatment plans. By understanding the genetic and epigenetic landscape of a child's disease, healthcare providers can tailor therapies to the individual's unique genetic makeup. For instance, genomic profiling can identify specific cancer mutations that respond to targeted therapies, enhancing treatment efficacy and reducing side effects.
